Search Results 931-940 of 17872 for monoclonal antibody

1. Project 4: P95HER2, Antitumor Immunity and the Efficacy of HER2-Directed Antibody Drug Conjugates - Mayo Clinic Research

   The development of trastuzumab in the early 2000s as an antibody-based targeted therapeutic for HER2+ breast cancer heralded a new era of precision medicine in ...

2. Publications - Udit Yadav, M.B.B.S. - Mayo Clinic

   ... monoclonal antibody. Eur J Haematol. 2023 Aug; 111 (2):318-321 Epub 2023 May 20. View PubMed; Vyas A, Isaac S, Kaur D, Yadav U. Role of the PLASMIC Score in ...

3. Assessing Pre-existing Antibodies to AAV in a Population of Patients With PKP2-Associated ARVC - Mayo Clinic

   Currently receiving systemic immunosuppressive therapy, cytotoxic chemotherapy, immunoglobulin therapy, or monoclonal antibody therapy. History of ...

4. Mayo Clinic Q and A: Surgical and nonsurgical treatment options for vaginal prolapse

   Monoclonal antibody treatment combo reduces hospitalization among high-risk patients with COVID-19 · 2021 Gerstner Awardees to investigate individualized ...

5. Study to Investigate the Safety and Effectiveness of Two Doses of the Antibody Drug GSK2857916 in Relapsed/Refractory Multiple Myeloma Patients - Mayo Clinic

   Prior treatment with a monoclonal antibody within 30 days of receiving the first dose of study drugs. Prior BCMA targeted therapy. Evidence of active ...

6. A Study to Assess Monoclonal B-cell Lymphocytosis in Individuals with Chronic Hepatitis C - Mayo Clinic

   To assess the proportion of individuals with MBL who have an improvement in the circulating monoclonal B-cell population following therapy with DAA ...

7. A Study of MPDL3280A (Anti-PD-L1 Antibody) Combined with Carboplatin and Paclitaxel , and with or without Bevacizumab, for Patients who have Stage IV Non-Squamous Non-Small Cell Lung Cancer - Mayo Clinic

   A Study of MPDL3280A (Anti-PD-L1 Antibody) Combined with Carboplatin and Paclitaxel , and with or without Bevacizumab, for Patients who have Stage IV Non- ...

8. Fallopian Tube Cancer Clinical Trials - Mayo Clinic Research

   Monoclonal antibodies, such as bevacizumab, may interfere with the ability of tumor cells to grow and spread. Using an Avatar, a living tumor sample with ...

9. Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) - Symptoms and causes - Mayo Clinic

   Myelin oligodendrocyte glycoprotein antibody-associated disease, also known as MOGAD, is a rare inflammatory disease that affects the central nervous system. In ...

10. A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab Monotherapy in Participants With Select B-Cell Malignancies (MorningSun) - Mayo Clinic

    monoclonal antibodies (MAbs) - Contraindication to tocilizumab - Prior ... - Prior anti-lymphoma treatment with any monoclonal antibody (e.g., anti-CD20),